Abstract: Cardiovascular disease (CVD) is the main cause of death and the most common disease worldwide. The aim of this review is to find the effectiveness of clinical pharmacist interventions with in the secondary prevention of CHD, using studies conducted on patients with heart failure and coronary heart disease. The study is based on electronic search results. Studies included were reported direct care from a clinical pharmacist in CHD or CHD-related therapeutic areas in collaboration with other health care workers with the following outcomes: CHD control or mortality, CHD risk factor control, patient-related outcomes (knowledge, adherence, or quality of life), and cost related to health care systems. The 2 studies says by providing …show more content…
The presence of a clinical pharmacist can help to decrease these problems and optimize patient therapy so as to achieve greater benefits.3 The European Society of Clinical Pharmacy defines the role of a clinical pharmacist as one that “develop[s] and promote[s] safe and appropriate drug use with the goal of optimizing patient care.”4 The American College of Clinical Pharmacy defines clinical pharmacy as a “health science discipline in which pharmacists provide patient care that optimizes medication therapy and promotes health, wellness, and disease prevention.”Clinical pharmacists may participate in such services as patient education, medicine management, or …show more content…
A comprehensive, systematic review was conducted, studies that evaluate the effects of clinical pharmacist intervention within a multidisciplinary team in the secondary prevention of CHD. The aim of this review was to identify the impact and effect of pharmacist interventions on adherence and outcomes .Since the intervention provided by clinical pharmacists to help control CHD risk factors is the same in primary and secondary prevention of CHD, we included studies evaluating the pharmacist effect in controlling CHD risk factors in both primary and secondary prevention.
Methods: We searched the following database of last 5 years from MEDLINE/ PubMed. The results were limited to published studies in the English. The literature search on medication adherence in HF patients was done by using common words “medication adherence,” “non- adherence,” “compliance,” “heart failure.” The pharmacist intervention literature search was conducted using the common key words “pharmacist,” “patient counselling” to evaluate any pharmacist intervention in the treatment of HF patients. The review also included studies that did not contain pharmacist intervention, instead of that improves medication adherence is